AUTHOR INDEX 403 Erbay, H. Perquin, C. W., Bertina, W., Hazebroek-Kampschreur, A. A. J. M Meralgia Paresthetica in Differential Diagnosis of Low-Back Pain. van Suijlekom-Smit, L. W. A.. Koes, B. W.. van der Wouden, J 13 C., Passchier, J.: Stability of Pain Parameters and Pain-Related Eriksson, M. Y. see Wilson, K. G. Quality of Life in Adolescents With Persistent Pain: A Three Year Follow-Up, 99 Fanciullo, G. J. see Katz, N. Ferrell, B. A. see Simmons, S. | Ideguchi, S. see Umino, M Fialka-Moser, V. see Strauss-Blasche, G Inturrisi, C. f Finch, P. M. see Roberts, L. J. Clinical Pharmacology of Opioids for Pain, $3 Fishman, S. M. Kreis, P. G.: The Opioid Contract, $70 Jabbari, B. see Difazio, M Flickinger, J. C. see Kondziolka, D Jamison, R. N. see Nedeljkovic, S. S Forouzanfar, T Jamison, R. N Kemler, M., Kessels, A. G. H., K6ke, A. J. A., van Kleef. M., Introduction, S1 Weber, W. E. J.: Comparison of Multiple Against Single Pain Jasser, S. see Cohen, M. J. M Intensity Measurements in Complex Regional Pain Syndrome Jensen, M. P. see Galer, B. S Type I: Analysis of 54 Patients, 234 Jensen, T. S. see Sindrup, S. H Freund, B. see Schwartz, M Joranson, D. E. see Gilson, A. M Freund, B. J. Schwartz, M.: Use of Botulinum Toxin in Chronic Whiplash- Kalizewski, T. see Thimineur, M Associated Disorder, $163 Kapoor, N Ciuffreda, K. J.. Tannen, B.: Complex Regional Pain Syndrome Gagliardi, G. see Ceccherelli, F. Type I: Associated Visual Sensorimotor Case Findings, 93 Gajraj, N. M. see Gatchel, R. J Katz, J. see Bergmans, L Galer, B. S. Katz, N Jensen, M. P., Ma, T., Davies, P. S.. Rowbotham, M. C.: The Li Fanciullo, G. J.: Role of Urine Toxicology Testing in the Manage docaine Patch 5% Effectively Treats All Neuropathic Pain Quali- ment of Chronic Opioid Therapy, $76 ties: Results of a Randomized, Double-Blind, Vehicle-Controlled, Keefe, F. J. see Lefebvre. J. C 3-Week Efficacy Study With Use of the Neuropathic Pain Scale, Kemler, M. see Forouzanfar, 7 297 Kessels, A. G. H. see Forouzanfar, 7 Gatchel, R. J Ketenci, A. see Yiicel, B Noe, C. E., Pulliam, C., Robbins, H., Deschner, M., Gajraj, N. M.. Kezar, L. see Putzke, J. D Vakharia, A. S.: A Preliminary Study of Multidimensional Pain Kirsh, K. I Inventory Profile Differences in Predicting Treatment Outcome in Whitcomb, L. A., Donaghy, K., Passik, S. D.: Abuse and Addiction a Heterogeneous Cohort of Patients with Chronic Pain, 139 Issues in Medically Ill Patients With Pain: Attempts at Clarifica Geertzen, J. H. B. see Reinders, M. F. tion of Terms and Empirical Study, $52 Geilen, M. see Vlaeyen, J. W. S. Kitaj, M. see Thimineur, M Geisser, M. E. see Roth, R. S Koes, B. W. see Hunfeld, J. A. M Giamberardino, M. A. see Panerai, A. I Kohase, H. see Umino, M Gilson, A. M Kéke, A. J. A. see Forouzanfar, T Joranson, D. E.: U.S. Policies Relevant to the Prescribing of Opioid Kollender, Y. see Abraham, R. B Analgesics for the Treatment of Pain in Patients With Addictive Kondziolka, D Disease, S91 Lunsford, L. D., Flickinger, J. C.: Stereotactic Radiosurgery for the Glogau, R. G rreatment of Trigeminal Neuralgia, 42 \ Review of the Use of Botulinum Toxin for Hyperhidrosis and Koot, H. M. see van Dijk, M Cosmetic Purposes, $191 Kravitz, E. see Thimineur, M Goodman, J. T. see Ellis, J. A. Kreis, P. G. see Fishman, S. M Goolkasian, P Kropmans, T. J. B Wheeler, A. H., Gretz, S. S.: The Neck Pain and Disability Scale Dijkstra, P. U., Stegenga, B., Stewart, R., de Bont, L. G. M.: Re Test-Retest Reliability and Construct Validity, 245 peated Assessment of Temporomandibular Joint Pain: Reasoned Gretz, S. S. see Goolkasian, P. Decision-Making With Use of Unidimensional and Multidimen sional Pain Scales, 107 Halbert. J. Kuo, M.-C. see Chia, Y.-Y Crotty, M., Cameron, I. D.: Evidence for the Optimal Management of Acute and Chronic Phantom Pain: A Systematic Review, 84 Lau, J. see Cepeda, M. S Harding, L. M. see Davies, S. J. Lefebvre. J. C Hazebroek-Kampschreur, A. A. J. M. see Hunfeld, J. A. M. Keefe, F. J.: Memory for Pain: The Relationshipo f Pain Catastroph Herron, P. D. see Cohen, M. J. M. izing to the Recall of Daily Rheumatoid Arthritis Pain, 56 Heuts, P. H. T. G. see Vlaeyen, J. W. S Lew, M. I Hicken, B. L. see Putzke, J. D. Review of the FDA-Approved Uses of Botulinum Toxins, Including Holmgren, H. see Vrethem, M. Data Suggesting Efficacy in Pain Reduction, $142 Hsieh, S.-W. see Chia, Y.-Y Lindstrém, T. see Vrethem, M Hunfeld, J. A. M. Liu, K. see Chia, Y.-Y The Clinical Journal of Pain, Vol. 18, No. 6, 2002 404 AUTHOR INDEX Loder, E. tions Between Pain, Grip Strength, and Manual Tests in the Treat- Biondi, D.: Use of Botulinum Toxins for Chronic Headaches: A ment Evaluation of Chronic Tennis Elbow, 164 Focused Review, $169 Pizzigallo, E. see Panerai, A. E. Lundsford, L. D. see Kondziolka, D. Poudevigne, M. S. Luskin, M. B. see Morin, C. O’Connor, P. J., Pasley, J. D.: Lack of Both Sex Differences and Influence of Resting Blood Pressure on Muscle Pain Intensity, Ma, T. see Galer, B. S. 386 Madsen, H. see Bajaj, P. Price, L. M. see Roberts, L. J. Malmivaara, A. see Pienimiki, T. Pullan, P. T. see Roberts, L. J. Margolis, C. G. see Cohen, M. J. M. Pulliam, C. see Gatchel, R. J. Marktl, W. see Strauss-Blasche, G. Putzke, J. D. Marouani, N. see Abraham, R. B. Richards, J. S.. Kezar, L., Hicken, B. L., Ness, T. J.: Long-Term Use Marshall, H. M. see Warms, C. A. of Gabapentin for Treatment of Pain After Traumatic Spinal Cord Melchart, H. see Strauss-Blasche, G. Injury, 116 Meller, I. see Abraham, R. B. Rappaport, Z. H. see Devor, M. Meroni, P. see Panerai, A. E. Mikail, S. F. see Wilson, K. G. Reed, B. A. see Chapman, S. L. Reid, C. W. see Ellis, J. A. Moliner, S. see Cerda-Olmedo, G. Morin, C. Reinders, M. F. Geertzen, J. H. B., Dijkstra, P. U.: Complex Regional Pain Syn- Bushnell, M. C., Luskin, M. B., Craig, A. D. (Bud): Disruption of Thermal Perception in a Multiple Sclerosis Patient With Central drome Type I: Use of the International Association for the Study Pain, 191 of Pain Diagnostic Criteria Defined in 1994, 207 Richards, J. S. see Putzke, J. D. Rigoni, M. T. see Ceccherelli, F. Nedeljkovic, S. S. Robbins, H. see Gatchel, R. J. Wasan, A., Jamison, R. N.: Assessment of Efficacy of Long-Term Roberts, L. J. Opioid Therapy in Pain Patients With Substance Abuse Potential, Finch, P. M., Pullan, P. T., Bhagat, C. I., Price, L. M.: Sex Hormone $39 Suppression by Intrathecal Opioids: A Prospective Study, 144 Ness, T. J. see Putzke, J. D. Roth, R. S. Ng, K. F. J Geisser, M. E.: Educational Achievement and Chronic Pain Disabil- Tsui, S. L., Chan, W. S.: Prevalence of Common Chronic Pain in ity: Mediating Role of Pain-Related Cognitions, 286 Hong Kong Adults, 275 Rowbotham, M. C. see Galer, B. S. Noe, C. E. see Gatchel, R. J Royal, M. A. see Smith, H. S. Nurmikko, T. J. see Peters, G. Ruzzante, L. see Ceccherelli, F. Nurmikko, T. J. Introduction, | Saad. H. H. A. see van Dijk, M. Sacerdote, P. see Panerai, A. E. O'Brien, C. F. Sakurai, N. see Umino, M. Treatment of Spasticity With Botulinum Toxin, $182 Savage, S. R. O’Connor, B. V. see Ellis, J. A. Assessment for Addiction in Pain-Treatment Settings, $28 O’Connor, P. J. see Poudevigne, M. S. Scarone, S. see Panerai, A. E. Olsson, I. Schmader, K. E. Bunketorp, O., Carlsson, S. G., Styf, J.: Prediction of Outcome in Epidemiology and Impact on Quality of Life of Postherpetic Neu- Whiplash-Associated Disorders Using West Haven—Yale Mullti- ralgia and Painful Diabetic Neuropathy, 350 dimensional Pain Inventory, 238 Schnelle, J. F. see Simmons, S. F. Ozyalcin, S. see Yiicel, B. Schnoll, S. see Weaver, M. Schulteis, G. see Wallace. M. S Panerai, A. E. Schwartz, M. see Freund, B. J. Vecchiet, J.. Panzeri, P., Meroni, P., Scarone, S., Pizzigallo, E., Schwartz, M. Giamberardino, M. A., Sacerdote, P.: Peripheral Blood Mono- Freund, B.: Treatment of Temporomandibular Disorders With Botu- nuclear Cell B-Endorphin Concentration Is Decreased in Chronic linum Toxin, $198 Fatigue Syndrome and Fibromyalgia but Not in Depression: Pre- Sertel, H. O. see Yiicel, B. liminary Report, 270 Setler, P. F. Panzeri, P. see Panerai, A. E. Therapeutic Use of Botulinum Toxins: Background and History, Pasley, J. D. see Poudevigne, M. S. S119 Passchier, J. see Hunfeld, J. A. M. Siira, P. see Pienimiki, T. Passchier, J. see van Dijk, M. Sim, J. Passik, S. D. see Kirsh, K. L. Adams, N.: Systematic Review of Randomized Controlled Trials of Perquin, C. W. see Hunfeld, J. A. M. Nonpharmacological Interventions for Fibromyalgia, 324 Peters, G. Simmons, S. F. Nurmikko, T. J.: Peripheral and Gasserian Ganglion-Level Proce- Ferrell, B. A., Schnelle, J. F.: Effects of a Controlled Exercise Trial dures for the Treatment of Trigeminal Neuralgia, 28 on Pain in Nursing Home Residents, 380 Pienimiki, T. Sindrup, S. H. Tarvainen, T., Siira, P., Malmivaara, A., Vanharanta, H.: Associa- Jensen, T. S.: Pharmacotherapy of Trigeminal Neuralgia, 22 The Clinical Journal of Pain, Vol. 18, No. 6, 2002 AUTHOR INDEX Smith, H. S. van der Wouden, J. C. see Hunfeld, J. A. M Audette, J., Royal, M. A.: Botulinum Toxin in Pain Management of van Dijk, M. Soft Tissue Syndromes, $147 Koot, H. M., Saad, H. H. A., Tibboel, D., Passchier, J.: Observa Snijdelaar, D. G. see Bergmans, L. tional Visual Analog Scale in Pediatric Pain Assessment: Useful Sood, P. see Thimineur, M Tool or Good Riddance?, 310 Stegenga, B. see Kropmans, T. J. B. van Kleef, M. see Forouzanfar, T Stewart, R. see Kropmans, T. J. B van Suijlekom-Smit, L. W. A. see Hunfeld, J. A. M Strain, E. C. Vanharanta, H. see Pienimiki, 1 Assessment and Treatment of Comorbid Psychiatric Disorders in Vecchiet, J. see Panerai, A. E. Opioid-Dependent Patients, S14 Viaeyen, J.W .S Strauss-Blasche, G. de Jong, J., Geilen, M., Heuts, P. H. T. G., van Breukelen. G.: The Ekmekcioglu, C., Vacariu, G., Melchart, H., Fialka-Moser. V.. Treatment of Fear of Movement/(Re)injury in Chronic Low Back Marktl, W.: Contribution of Individual Spa Therapies in the Pain: Further Evidence on the Effectiveness of Exposure In Vivo, Treatment of Chronic Pain, 302 251 Styf, J. see Olsson, I. Vrethem, M Sun, G.-C. see Chia, Y.-Y. Boivie. J., Arnqvist, H.. Holmgren, H., Lindstrém, T.: Painful Poly neuropathy in Patients With and Without Diabetes: Clinical, Neu Talu, G. K. see Yiicel, B. rophysiologic, and Quantitative Sensory Characteristics, 122 Tannen, B. see Kapoor, N Tarvainen, T. see Pienimiiki. T. Wallace, M. S. Thimineur, M Braun, J., Schulteis, G.: Postdelivery of Alfentanil and Ketamine Kitaj, M., Kravitz, E., Kalizewski, T., Sood, P.: Functional Abnor- Has No Effect on Intradermal Capsaicin—Induced Pain and Hy malities of the Cervical Cord and Lower Medulla and Their Effect peralgesia, 373 on Pain: Observations in Chronic Pain Patients With Incidental Warms, C. A Mild Chiari | Malformation and Moderate to Severe Cervical Turner, J. A.. Marshall, H. M., Cardenas, D. D.: Treatments for Cord Compression, 171 Chronic Pain Associated With Spinal Cord Injuries: Many Are Thompson, D Tried, Few Are Helpful, 154 Toward a Pharmacoeconomic Model of Neuropathic Pain, 366 Wasan, A. see Nedeljkovic, S. S Tibboel, D. see van Dijk, M. Weaver. M Tsui, S. L. see Ng, mh. ©. 3. Schnoll, S.: Abuse Liability in Opioid Therapy for Pain Treatment in Turk, D. C. Patients With an Addiction History, S61 Clinical Effectiveness and Cost-Effectiveness of Treatments for Pa- Weber, W. E. J. see Forouzanfar, 1 tients With Chronic Pain, 355 Weinbroum, A. A. see Abraham, R. B Turk, D. C. Wheeler, A. H. see Goolkasian, P Remember the Distinction Between Malignant and Benign Pain? Whitcomb, L. A. see Kirsh, K. I Well, Forget It, 75 Wilson, K. G Turner, J. A. see Warms, C. A Eriksson, M. Y., D’Eon, J. L., Mikail, S. F., Emery, P. C.: Major Depression and Insomnia in Chronic Pain, 77 Umino, M. Kohase, H., Ideguchi, S., Sakurai, N.: Long-Term Pain Control in Yiicel, B Trigeminal Neuralgia With Local Anesthetics Using an Indwell- Ozyalcin, S., Sertel, H. O., Camlica, H., Ketenci, A., Talu, G. K ing Catheter in the Mandibular Nerve, 196 Childhood Traumatic Events and Dissociative Experiences in Pa tients With Chronic Headache and Low Back Pain, 394 Vacariu, G. see Strauss-Blasche, G Vakharia, A. S. see Gatchel, R. J. Zakrzewska, J. M. van Breukelen, G. see Vlaeyen, J. W. S. Diagnosis and Differential Diagnosis of Trigeminal Neuralgia, 14 The Clinical Journal of Pain 18:405-412 © 2002 Lippincott Williams & Wilkins, Inc., Philadelphia The Clinical Journal of Pain Volume 18, 2002 Subject Index Accommodation Therapeutic use of botulinum toxins: Background and history, Complex regional pain syndrome type I: Associated visual senso- S119 rimotor case findings, 93 Acupuncture Acetylcholine Comparison of superficial and deep acupuncture in the treatment Possible mechanisms for the effects of botulinum toxin on pain, of lumbar myofascial pain: A double-blind randomized con- $125 trolled study, 149 The Clinical Journalo f Pain, Vol. 18, No, 6, 2002 SUBJECT " INDEX Addiction Blepharospasm Abuse and addiction issues in medically ill patients with pain: Review of the FDA-approved uses of botulinum toxins, including Attempts at clarification of terms and empirical study, $52 data suggesting efficacy in pain reduction, $142 Abuse liability in opioid therapy for pain treatment in patients Blood pressure with an addiction history, S61 Lack of both sex differences and influence of resting blood pres- Assessment for addiction in pain-treatment settings, $28 sure on muscle pain intensity, 386 Ethical perspectives: Opioid treatment of chronic pain in the con- Book reviews text of addiction, S99 Acute pain management: A practical guide, 2nd edition, 338 U. S. policies relevant to the prescribing of opioid analgesics for Bonica’s management of pain, 3rd edition, 339 the treatment of pain in patients with addictive disease, S91 Neuropathic pain: Pathophysiology and treatment progress in pain Addictive opioid-related disorders research and management, Volume 21, 337 Role of urine toxicology testing in the management of chronic Botox opioid therapy, S76 A focused review of the use of botulinum toxin for low back pain, Adherence S155 Role of urine toxicology testing in the management of chronic Review of the FDA-approved uses of botulinum toxins, including opioid therapy, S76 data suggesting efficacy in pain reduction, $142 Adolescents Review of the use of botulinum toxin for hyperhidrosis and cos- Stability of pain parameters and pain-related quality of life in ado- metic purposes, S191 lescents with persistent pain: A three-year follow-up, 99 Use of botulinum toxin for chronic headaches: A focused review, Agreement analysis S169 Comparison of multiple against single pain intensity measurements Botulinum toxin in complex regional pain syndrome type I: Analysis of 54 Botulinum toxin in pain management of soft tissue syndromes, patients, 234 $147 Alfentanil Postdelivery of alfentanil and ketamine has no effects on intrader- Considering the immune response to botulinum toxin, $133 mal capsaicin-induced pain and hyperalgesia, 373 A focused review of the use of botulinum toxin for low back pain, Analgesia S155 Does postoperative pain induce emesis?, 317 A focused review on the use of botulinum toxin for neuropathic Review of the FDA-approved uses of botulinum toxins, including pain, $177 data suggesting efficacy in pain reduction, $142 Possible mechanisms for the effects of botulinum toxin on pain, Analgesics $125 Clinical pharmacology of opioids for pain, S3 Review of the FDA-approved uses of botulinum toxins, including A focused review on the use of botulinum toxin for neuropathic data suggesting efficacy in pain reduction, $142 pain, S177 Review of the use of botulinum toxin for hyperhidrosis and cos- Role of urine toxicology testing in the management of chronic metic purposes, S19] opioid therapy, S76 Therapeutic use of botulinum toxins: Background and history, U. S. policies relevant to the prescribing of opioid analgesics for S119 the treatment of pain in patients with addictive disease, S91 Treatment of spasticity with botulinum toxin, S182 Anticonvulsants Treatment of temporomandibular disorders with botulinum toxin, Clinical effectiveness and cost-effectiveness of treatments for pa- S198 tients with chronic pain, 355 Use of botulinum toxin for chronic headaches: A focused review, Antidepressants $169 Clinical effectiveness and cost-effectiveness of treatments for pa- Use of botulinum toxin in chronic whiplash-associated, $163 tients with chronic pain, 355 Anxiety Cancer The treatment of fear of movement/(re)injury in chronic low back Dextromethorphan for phantom limb pain attenuation in cancer pain: Evidence on the effectiveness of exposure in vivo, 251] amputees: A double-blind crossover trial involving three pa- Anxiety disorders tients, 282 Assessment and treatment of comorbid psychiatric disorders in Capsaicin opioid-dependent patients, S14 Postdelivery of alfentanil and ketamine has no effects on intrader- Assessment mal capsaicin-induced pain and hyperalgesia, 373 Assessment for addiction in pain-treatment settings, S28 Case report Assessment of efficacy of long-term opioid therapy in pain pa- Disruption of thermal perception in a multiple sclerosis patient tients with substance abuse potential, $39 with central pain, 19] Effects of controlled exercise trial on pain in nursing home resi- Long-term pain control in trigeminal neuralgia with local anesthet- dents, 380 ics using an indwelling catheter in the mandibular nerve, 196 Management of progressive pain in a patient with intramedullary Back pain chordoma of the spine, 128 Contribution of individual spa therapies in the treatment of Methadone for phantom limb pain, 203 chronic pain, 302 A novel treatment of postherpetic neuralgia using peppermint oil, 200 Balneotherapy Catastrophizing Contribution of individual spa therapies in the treatment of Memory for pain: The relationship of pain catastrophizing to the chronic pain, 302 recall of daily rheumatoid arthritis pain, 56 Barriers Causalgia U. S. policies relevant to the prescribing of opioid analgesics for Defining the therapeutic role of local anesthetic sympathetic the treatment of pain in patients with addictive disease, S91 blockade in complex regional pain syndrome: A narrative and 6-Endorphin concentration systematic review, 216 Peripheral blood mononuclear cell B-endorphin concentration is Central pain decreased in chronic fatigue syndrome and fibromyalgia but An overview of neuropathic pain: Syndromes, symptoms, signs, not in depression: Preliminary report, 270 and several mechanisms, 343 The Clinical Journal of Pain, Vol. 18, No, 6, 2002 SUBJECT INDEX Disruption of thermal perception in a multiple sclerosis patient Cognition with central pain, 19] Educational achievement and chronic pain disability: Mediating Therapeutic extradural cortical stimulation for central and neuro role of pain-related cognitions, 286 pathic pain: A review, 48 Effects of intermediate- and long-term use of opioids on cognition Cervical cord compression in patients with chronic pain, $83 Functional abnormalities of the cervical cord and lower medulla Cognitive-behavioral treatment and their effect on pain: Observations in chronic pain patients The treatment of fear of movement/(re)injury in chronic low back with incidental mild Chiari | malformation and moderate to pain: Evidence on the effectiveness of exposure in vivo, 251 severe cervical cord compression, 171 Cold allodynia Cervical dystonia Disruption of thermal perception in a multiple sclerosis patient Review of the FDA-approved uses of botulinum toxins, including with central pain, 191 data suggesting efficacy in pain reduction, $142 Comorbid psychiatric disorders Cervical pain Assessment and treatment of comorbid psychiatric disorders in The Neck Pain and Disability Scale: Test-retest reliability and opioid-dependent patients, S14 construct validity, 245 Complex regional pain syndrome Cervical sprain Comparison of multiple against single pain intensity measurements in complex regional pain syndrome type I: Analysis of 54 Use of botulinum toxin in chronic whiplash-associated, $163 patients, 234 Chiari | malformation Complex regional pain syndrome type I: Associated visual senso Functional abnormalities of the cervical cord and lower medulla rimotor case findings, 93 and their effect on pain: Observations in chronic pain patients Complex regional pain syndrome type I: Use of the International with incidental mild Chiari | malformation and moderate to Association for the Study of Pain Diagnostic Criteria defined severe cervical cord compression, 171 in 1994, 207 Childhood abuse Defining the therapeutic role of local anesthetic sympathetic Childhood traumatic events and dissociative experiences in pa blockade in complex regional pain syndrome: A narrative and tients with chronic headache and low back pain, 394 systematic review, 216 China A focused review on the use of botulinum toxin for neuropathic Prevalence of common chronic pain in Hong Kong adults, 2 pain, $177 Chordoma Functional abnormalities of the cervical cord and lower medulla Management of progressive pain in a patient with intramedullary and their effect on pain: Observations in chronic pain patients chordoma of the spine, 128 with incidental mild Chiari | malformation and moderate to Chronic fatigue syndrome severe cervical cord compression, 171 Peripheral blood mononuclear cell 6-endorphin concentration is Contract decreased in chronic fatigue syndrome and fibromyalgia but Phe opioid contract, S70 not in depression: Preliminary report, 270 Cosmetic Chronic opioid therapy Review of the use of botulinum toxin for hyperhidrosis and cos Effects of intermediate- and long-term use of opioids on cognition metic purposes, S19] in patients with chronic pain, $83 Cost-effectiveness The opioid contract, $70 Clinical effectiveness and cost-effectiveness of treatments for pa Role of urine toxicology testing in the management of chronic tients with chronic pain, 355 opioid therapy, S76 Toward a pharmacoeconomic model of neuropathic pain, 366 Chronic pain Cranial nerve neuralgia Abuse and addiction issues in medically ill patients with pain Pathophysiology of trigeminal neuralgia: The ignition hypothesis, 4 Attempts at clarification of terms and empirical study, S52 \n overview of neuropathic pain: Syndromes, symptoms, signs, Daily pain and several mechanisms, 343 Memory for pain: The relationship of pain catastrophizing to the Assessment and treatment of comorbid psychiatric disorders in recall of daily rheumatoid arthritis pain, 56 opioid-dependent patients, S14 Decision-making Assessment of efficacy of long-term opioid therapy in pain pa- Repeated assessment of temporomandibular joint pain: Reasoned tients with substance abuse potential, $39 decision-making with use of unidimensional and multidimen Clinical effectiveness and cost-effectiveness of treatments for pa- sional pain scales, 107 tients with chronic pain, 355 Dementia Contribution of individual spa therapies in the treatment of Nursing staff members’ perceptions of pain indicators in persons chronic pain, 302 with severe dementia, 64 Educational achievement and chronic pain disability: Mediating Demyelination role of pain-related cognitions, 286 Treatment of spasticity with botulinum toxin, $182 Effects of intermediate- and long-term use of opioids on cognition Depression in patients with chronic pain, $83 Assessment and treatment of comorbid psychiatric disorders in Major depression and insomnia in chronic pain, 77 opioid-dependent patients, S14 A preliminary study of multidimensional pain inventory profile Major depression and insomnia in chronic pain, 77 differences in predicting treatment outcome in a heteroge Peripheral blood mononuclear cell 6-endorphin concentration 1s neous cohort of patients with chronic pain, 139 decreased in chronic fatigue syndrome and fibromyalgia but Prevalence of common chronic pain in Hong Kong adults, 275 not in depression: Preliminary report, 270 Stability of pain parameters and pain-related quality of life in ado- Dextromethorphan lescents with persistent pain: A three-year follow-up, 99 Dextromethorphan for phantom limb pain attenuation in cancer Clinical examination amputees: A double-blind crossover trial involving three pa- Associations between pain, grip strength, and manual tests in the tients, 282 treatment evaluation of chronic tennis elbow, 164 Diabetes Clinical trial Painful polyneuropathy in patients with and without diabetes: Long-term use of gabapentin for treatment of pain after traumatic Clinical, neurophysiologic, and quantitative sensory character spinal cord injury, 116 istics, 122 The Clinical Journalo f Pain, Vol. 18, No. 6, 2002 408 SUBJECT INDEX Diabetes mellitus Ethics Epidemiology and impact on quality of life of postherpetic neural- Ethical perspectives: Opioid treatment of chronic pain in the con- gia and painful diabetic neuropathy, 350 text of addiction, S99 Diabetic neuralgia Euphoria Epidemiology and impact on quality of life of postherpetic neural- Clinical pharmacology of opioids for pain, $3 gia and painful diabetic neuropathy, 350 Exercise Diabetic neuropathy Effects of controlled exercise trial on pain in nursing home resi- An overview of neuropathic pain: Syndromes, symptoms, signs, dents, 380 and several mechanisms, 343 Lack of both sex differences and influence of resting blood pres- A focused review on the use of botulinum toxin for neuropathic sure on muscle pain intensity, 386 pain, S177 Experimental studies Diagnosis Postdelivery of alfentanil and ketamine has no effects on intrader- Diagnosis and differential diagnosis of trigeminal neuralgia, 14 mal capsaicin-induced pain and hyperalgesia, 373 Diagnostic criteria Exposure in vivo Complex regional pain syndrome type I: Use of the International The treatment of fear of movement/(re)injury in chronic low back Association for the Study of Pain Diagnostic Criteria defined pain: Evidence on the effectiveness of exposure in vivo, 251 in 1994, 207 Eye movements Disability measurement Complex regional pain syndrome type I: Associated visual senso- Educational achievement and chronic pain disability: Mediating rimotor case findings, 93 role of pain-related cognitions, 286 The Neck Pain and Disability Scale: Test-retest reliability and Family construct validity, 245 Stability of pain parameters and pain-related quality of life in ado- Dissociative experiences lescents with persistent pain: A three-year follow-up, 99 Childhood traumatic events and dissociative experiences in pa- Fatigue tients with chronic headache and low back pain, 394 Complex regional pain syndrome type I: Associated visual senso- Double-blind controlled study rimotor case findings, 93 Comparison of superficial and deep acupuncture in the treatment Fear-avoidance beliefs of lumbar myofascial pain: A double-blind randomized con- The treatment of fear of movement/(re)injury in chronic low back trolled study, 149 pain: Evidence on the effectiveness of exposure in vivo, 251 Double-blind crossover study Fibromyalgia Dextromethorphan for phantom limb pain attenuation in cancer Botulinum toxin in pain management of soft tissue syndromes, amputees: A double-blind crossover trial involving three pa- S147 tients, 282 Functional abnormalities of the cervical cord and lower medulla Drug abuse. see Substance abuse and their effect on pain: Observations in chronic pain patients Drugs with incidental mild Chiari | malformation and moderate to Pharmacotherapy of trigeminal neuralgia, 22 severe cervical cord compression, 171 Drug-seeking behavior Peripheral blood mononuclear cell 8-endorphin concentration is Abuse liability in opioid therapy for pain treatment in patients decreased in chronic fatigue syndrome and fibromyalgia but with an addiction history, S61 not in depression: Preliminary report, 270 Dystonia Systematic review of randomized controlled trials of nonpharma- Botulinum toxin in pain management of soft tissue syndromes, cological interventions for fibromyalgia, 324 $147 Follow-up Possible mechanisms for the effects of botulinum toxin on pain, Stability of pain parameters and pain-related quality of life in ado- $125 lescents with persistent pain: A three-year follow-up, 99 Therapeutic use of botulinum toxins: Background and history, Functional capacity S119 Associations between pain, grip strength, and manual tests in the treatment evaluation of chronic tennis elbow, 164 Economics Gabapentin Toward a pharmacoeconomic model of neuropathic pain, 366 Long-term use of gabapentin for treatment of pain after traumatic Editorials spinal cord injury, 116 Remember the distinction between malignant and benign pain? Gender Well, forget it, 75 Lack of both sex differences and influence of resting blood pres- Educational attainment sure on muscle pain intensity, 386 Educational achievement and chronic pain disability: Mediating Generalizability role of pain-related cognitions, 286 Repeated assessment of temporomandibular joint pain: Reasoned Efficacy decision-making with use of unidimensional and multidimen- Pharmacotherapy of trigeminal neuralgia, 22 sional pain scales, 107 Elderly Grip strength Nursing staff members’ perceptions of pain indicators in persons Associations between pain, grip strength, and manual tests in the with severe dementia, 64 treatment evaluation of chronic tennis elbow, 164 Emesis Does postoperative pain induce emesis?, 317 Headache Endogenous opioid Childhood traumatic events and dissociative experiences in pa- Clinical pharmacology of opioids for pain, S3 tients with chronic headache and low back pain, 394 Epidural anesthesia Use of botulinum toxin for chronic headaches: A focused review, Evidence for the optimal management of acute and chronic phan- S169 tom pain: A systematic review, 84 Heat Errata A comparison of modality-specific somatosensory changes during Therapeutic extradural cortical stimulation for central and neuro- menstruation in dysmenorrheic and nondysmenorrheic pathic pain: A review, 195 women, 180 The Clinical Journal of Pain, Vol. 18, No. 6, 2002 SUBJECT " INDEX Hemifacial spasm Letters to the editor Review of the FDA-approved uses of botulinum toxins, including A comparison of blacks and whites seeking treatment for chronic data suggesting efficacy in pain reduction, $142 pain, 136 Herniated disc Lidocaine patch A focused review of the use of botulinum toxin for low back pain The lidocaine patch 5% effectively treats all neuropathic pain S155 qualities: Results of a randomized, double-blind, vehicle-con- Herpes zoster trolled, 3-week efficacy study with use of the Neuropathic Epidemiology and impact on quality of life of postherpetic neural- Pain Scale, 297 gia and painful diabetic neuropathy, 350 Local anesthetics Human clinical trial Long-term pain control in trigeminal neuralgia with local anesthet- Comparison of superficial and deep acupuncture in the treatment ics using an indwelling catheter in the mandibular nerve, 196 of lumbar myofascial pain: A double-blind randomized con- Long-term pain control trolled study, 149 Long-term pain control in trigeminal neuralgia with local anesthet Hyperhidrosis ics using an indwelling catheter in the mandibular nerve, 196 Review of the use of botulinum toxin for hyperhidrosis and cos- Low back pain metic purposes, S19] Childhood traumatic events and dissociative experiences in pa- Hypogonadism tients with chronic headache and low back pain, 394 Sex hormone suppression by intrathecal opioids: A prospective Comparison of superficial and deep acupuncture in the treatment study, 144 of lumbar myofascial pain: A double-blind randomized con Hypothalamic-pituitary-gonadal axis trolled study, 149 Sex hormone suppression by intrathecal opioids: A prospective A focused review of the use of botulinum toxin for low back pain study, 144 Si55 Meralgia paresthetica in differential diagnosis of low-back pain, Immune response 132 Considering the immune response to botulinum toxin, $133 The treatment of fear of movement/(re)injury in chronic low back Immune system pain: Evidence on the effectiveness of exposure in vivo, 251 Peripheral blood mononuclear cell B-endorphin concentration is decreased in chronic fatigue syndrome and fibromyalgia but Magnetic resonance imaging not in depression: Preliminary report, 270 Diagnosis and differential diagnosis of trigeminal neuralgia, 14 Immunogenicity Mandibular nerve Considering the immune response to botulinum toxin, $133 Long-term pain control in trigeminal neuralgia with local anesthet- Impairment ics using an indwelling catheter in the mandibular nerve, 196 Associations between pain, grip strength, and manual tests in the McGill Pain Questionnaire treatment evaluation of chronic tennis elbow, 164 A comparison of modality-specific somatosensory changes during Implantable drug delivery systems menstruation in dysmenorrheic and nondysmenorrheic Clinical effectiveness and cost-effectiveness of treatments for pa women, 180 tients with chronic pain, 355 Medical decision-making Indwelling catheter Ethical perspectives: Opioid treatment of chronic pain in the con Long-term pain control in trigeminal neuralgia with local anesthet- text of addiction, S99 ics using an indwelling catheter in the mandibular nerve, 196 Medical illness Insomnia Abuse and addiction issues in medically ill patients with pain: Major depression and insomnia in chronic pain, 7 Attempts at clarification of terms and empirical study, $52 Interdisciplinary treatment Medication misuse/abuse A preliminary study of multidimensional pain inventory profile Abuse liability in opioid therapy for pain treatment in patients differences in predicting treatment outcome in a heteroge- with an addiction history, S61 neous cohort of patients with chronic pain, 139 Memory for pain International Association for the Study of Pain Memory for pain: The relationship of pain catastrophizing to the Complex regional pain syndrome type I: Use of the International recall of daily rheumatoid arthritis pain, 56 Association for the Study of Pain Diagnostic Criteria defined Menstrual pain in 1994, 207 A comparison of modality-specific somatosensory changes during Interviews menstruation in dysmenorrheic and nondysmenorrheic women Stability of pain parameters and pain-related quality of life in ado- Menthol lescents with persistent pain: A three-year follow-up, 99 \ novel treatment of postherpetic neuralgia using peppermint oil, Intractable behavior 200 Role of urine toxicology testing in the management of chronic Meralgia paresthetica opioid therapy, S76 Meralgia paresthetica in differential diagnosis of low-back pain, 132 Intraspinal opioids Meta-analysis Sex hormone suppression by intrathecal opioids: A prospective Defining the therapeutic role of local anesthetic sympathetic study, 144 blockade in complex regional pain syndrome: A narrative and Intraventricular approach systematic review, 216 Management of progressive pain in a patient with intramedullary Methadone chordoma of the spine, 128 Methadone for phantom limb pain, 203 Methodology Ketamine Comparison of superficial and deep acupuncture in the treatment Postdelivery of alfentanil and ketamine has no effects on intrader- of lumbar myofascial pain: A double-blind randomized con- mal capsaicin-induced pain and hyperalgesia, 373 trolled study, 149 N-Methyl-D-aspartate Lateral epicondylitis Dextromethorphan for phantom limb pain attenuation in cancer Associations between pain, grip strength, and manual tests in the amputees: A double-blind crossover trial involving three pa- treatment evaluation of chronic tennis elbow, 164 tients, 282 The Clinical Journal of Pain, Vol. 18, No. 6, 2002 SUBJECT * INDEX Microvascular decompression A novel treatment of postherpetic neuralgia using peppermint oil, Microvascular decompression, 35 200 Pathophysiology of trigeminal neuralgia: The ignition hypothesis, 4 Peripheral and Gasserian ganglion-level procedures for the treat- Modeling ment of trigeminal neuralgia, 28 Toward a pharmacoeconomic model of neuropathic pain, 366 Therapeutic extradural cortical stimulation for central and neuro- Morphine pathic pain: A review, 48 Does postoperative pain induce emesis?, 317 Toward a pharmacoeconomic model of neuropathic pain, 366 Effects of intermediate- and long-term use of opioids on cognition Neuropathic Pain Scale in patients with chronic pain, S83 The lidocaine patch 5% effectively treats all neuropathic pain Sex hormone suppression by intrathecal opioids: A prospective qualities: Results of a randomized, double-blind, vehicle-con- study, 144 trolled, 3-week efficacy study with use of the Neuropathic Morphinelike agonist Pain Scale, 297 Clinical pharmacology of opioids for pain, S3 Neurotoxin Motor cortex stimulation Possible mechanisms for the effects of botulinum toxin on pain, Therapeutic extradural cortical stimulation for central and neuro- $125 pathic pain: A review, 48 Therapeutic use of botulinum toxins: Background and history, Multidimensional Pain Inventory S119 Prediction of outcome in whiplash-associated disorders using West Nociceptive pain Haven-Yale Multidimensional Pain Inventory, 238 A focused review on the use of botulinum toxin for neuropathic A preliminary study of multidimensional pain inventory profile pain, S177 differences in predicting treatment outcome in a heteroge- Nociceptor neous cohort of patients with chronic pain, 139 A focused review of the use of botulinum toxin for low back pain, Multiple pain rating $155 Comparison of multiple against single pain intensity measurements Nonpharmacological treatment in complex regional pain syndrome type I: Analysis of 54 Systematic review of randomized controlled trials of nonpharma- patients, 234 cological interventions for fibromyalgia, 324 Multiple sclerosis Nursing homes Disruption of thermal perception in a multiple sclerosis patient Effects of controlled exercise trial on pain in nursing home resi with central pain, 19] dents, 380 Muscle pain Nursing staff members’ perceptions of pain indicators in persons Lack of both sex differences and influence of resting blood pres- with severe dementia, 64 sure on muscle pain intensity, 386 Myobloc A focused review of the use of botulinum toxin for low back pain, Opioid dependence S155 Assessment and treatment of comorbid psychiatric disorders in Review of the FDA-approved uses of botulinum toxins, including opioid-dependent patients, S14 data suggesting efficacy in pain reduction, $142 Opioid pain Review of the use of botulinum toxin for hyperhidrosis and cos- Role of urine toxicology testing in the management of chronic metic purposes, $19] opioid therapy, S76 Use of botulinum toxin for chronic headaches: A focused review, Opioid receptor $169 Clinical pharmacology of opioids for pain, S3 Myofascial pain Opioid rotation Comparison of superficial and deep acupuncture in the treatment Clinical pharmacology of opioids for pain, S3 of lumbar myofascial pain: A double-blind randomized con- Opioids trolled study, 149 Assessment for addiction in pain-treatment settings, S28 Assessment of efficacy of long-term opioid therapy in pain pa- Neck pain tients with substance abuse potential, S39 The Neck Pain and Disability Scale: Test-retest reliability and Clinical effectiveness and cost-effectiveness of treatments for pa- construct validity, 245 tients with chronic pain, 355 Prediction of outcome in whiplash-associated disorders using West Effects of intermediate- and long-term use of opioids on cognition Haven-Yale Multidimensional Pain Inventory, 238 in patients with chronic pain, S83 Use of botulinum toxin in chronic whiplash-associated, $163 The opioid contract, $70 Nerve blocks U. S. policies relevant to the prescribing of opioid analgesics for Evidence for the optimal management of acute and chronic phan- the treatment of pain in patients with addictive disease, S91 tom pain: A systematic review, 84 Orofacial pain Nerve pathophysiology Treatment of temporomandibular disorders with botulinum toxin, Pathophysiology of trigeminal neuralgia: The ignition hypothesis, 4 $198 Neural pathways Outcome evaluation Treatment of spasticity with botulinum toxin, $182 Assessment of efficacy of long-term opioid therapy in pain pa- Neurontin tients with substance abuse potential, $39 Long-term use of gabapentin for treatment of pain after traumatic spinal cord injury, 116 Neuropathic pain Pain An overview of neuropathic pain: Syndromes, symptoms, signs, Effects of controlled exercise trial on pain in nursing home resi- and several mechanisms, 343 dents, 380 A focused review on the use of botulinum toxin for neuropathic Nursing staff members’ perceptions of pain indicators in persons pain, S177 with severe dementia, 64 The lidocaine patch 5% effectively treats all neuropathic pain Possible mechanisms for the effects of botulinum toxin on pain, qualities: Results of a randomized, double-blind, vehicle-con- $125 trolled, 3-week efficacy study with use of the Neuropathic Review of the FDA-approved uses of botulinum toxins, including Pain Scale, 297 data suggesting efficacy in pain reduction, $142 The Clinical Journal of Pain, Vol. 18, No. 6, 2002 SUBJECT INDEX Therapeutic use of botulinum toxins: Background and history, Policy S119 U. S. policies relevant to the prescribing of opioid analgesics for Treatments for chronic pain associated with spinal cord injuries the treatment of pain in patients with addictive disease, $91 Many are tried, few are helpful, 154 Polyneuropathy Use of botulinum toxin for chronic headaches: A focused review, Painful polyneuropathy in patients with and without diabetes S169 Clinical, neurophysiologic, and quantitative sensory character Pain beliefs istics, 122 Educational achievement and chronic pain disability: Mediating Population role of pain-related cognitions, 286 Prevalence of common chronic pain in Hong Kong adults, 275 Pain management Postherpetic neuralgia The lidocaine patch 5% effectively treats all neuropathic pain An overview of neuropathic pain: Syndromes, symptoms, signs, qualities: Results of a randomized, double-blind, vehicle-con- and several mechanisms, 343 trolled, 3-week efficacy study with use of the Neuropathic Epidemiology and impact on quality of life of postherpetic neural Pain Scale, 297 gia and painful diabetic neuropathy, 350 Pain in hospitalized pediatric patients: How are we doing?, 262 \ focused review on the use of botulinum toxin for neuropathic U. S. policies relevant to the prescribing of opioid analgesics for pain, $177 the treatment of pain in patients with addictive disease, S91 The lidocaine patch 5% effectively treats all neuropathic pain Pain measurement qualities: Results of a randomized, double-blind, vehicle-con- The Neck Pain and Disability Scale: Test-retest reliability and trolled, 3-week efficacy study with use of the Neuropathic construct validity, 245 Pain Scale, 297 Pain mechanism \ novel treatment of postherpetic neuralgia using peppermint oil, 200 The lidocaine patch 5% effectively treats all neuropathic pain Postoperative pain qualities: Results of a randomized, double-blind, vehicle-con- Does postoperative pain induce emesis?, 317 trolled, 3-week efficacy study with use of the Neuropathic Pain Scale, 297 Pressure Pain-patient heterogeneity \ comparison of modality-specific somatosensory changes during A preliminary study of multidimensional pain inventory profile menstruation in dysmenorrheic and nondysmenorrheic women Prevalence differences in predicting treatment outcome in a heteroge- neous cohort of patients with chronic pain, 139 Prevalence of common chronic pain in Hong Kong adults, 275 Pain prevalence Principle of double effect Pain in hospitalized pediatric patients: How are we doing?, Ethical perspectives: Opioid treatment of chronic pain in the con text of addiction, S99 262 Pain rating index Pseudoaddiction Abuse liability in opioid therapy for pain treatment ia patients Repeated assessment of temporomandibular joint pain: Reasoned with an addiction history, S61 decision-making with use of unidimensional and multidimen- sional pain scales, 107 Ethical perspectives: Opioid treatment of chronic pain in the con text of addiction, $99 Pain rehabilitation program Psychometrics Clinical effectiveness and cost-effectiveness of treatments for pa Observational visual analog scale in pediatric pain assessment tients with chronic pain, 355 Pain threshold Useful tool or good riddance?, 310 Prediction of outcome in whiplash-associated disorders using West Associations between pain, grip strength, and manual tests in the treatment evaluation of chronic tennis elbow, 164 Haven-Yale Multidimensional Pain Inventory, 238 Psychomotor tasks Patient-controlled analgesia Effects of intermediate- and long-term use of opioids on cognition Does postoperative pain induce emesis?, 317 Pediatric pain in patients with chronic pain, $83 Observational visual analog scale in pediatric pain assessment: Quality of life Useful tool or good riddance?, 310 Contribution of individual spa therapies in the treatment of Pain in hospitalized pediatric patients: How are we doing?, 262 chronic pain, 302 Peppermint Epidemiology and impact on quality of life of postherpetic neural A novel treatment of postherpetic neuralgia using peppermint oil, gia and painful diabetic neuropathy, 350 200 Ethical perspectives: Opioid treatment of chronic pain in the con- Peripheral blood mononuclear cells text of addiction, $99 Peripheral blood mononuclear cell B-endorphin concentration is Stability of pain parameters and pain-related quality of life in ado- decreased in chronic fatigue syndrome and fibromyalgia but lescents with persistent pain: A three-year follow-up, 99 not in depression: Preliminary report, 270 Personality disorders Radiosurgery Assessment and treatment of comorbid psychiatric disorders in Stereotactic radiosurgery for the treatment of trigeminal neuralgia, opioid-dependent patients, $14 42 Phantom limb pain Randomized controlled trials Dextromethorphan for phantom limb pain attenuation in cancer Systematic review of randomized controlled trials of nonpharma- amputees: A double-blind crossover trial involving three pa- cological interventions for fibromyalgia, 324 tients, 282 Reflex sympathetic dystrophy Evidence for the optimal management of acute and chronic phan- Complex regional pain syndrome type I: Associated visual senso- tom pain: A systematic review, 84 rimotor case findings, 93 Methadone for phantom limb pain, 203 Defining the therapeutic role of local anesthetic sympathetic Pharmacoeconomic model blockade in complex regional pain syndrome A narrative and Toward a pharmacoeconomic model of neuropathic pain, 366 systematic review, 216 Physical therapy Rehabilitation Contribution of individual spa therapies in the treatment of Associations between pain, grip strength, and manual tests in the chronic pain, 302 treatment evaluation of chronic tennis elbow, 164 The Clinical Journalo f Pain, Vol. 18, No. 6, 2002 412 SUBJECT INDEX Reliability Survey Repeated assessment of temporomandibular joint pain: Reasoned Treatments for chronic pain associated with spinal cord injuries: decision-making with use of unidimensional and multidimen- Many are tried, few are helpful, 154 sional pain scales, 107 Systematic review Review Complex regional pain syndrome type I: Use of the International Peripheral and Gasserian ganglion-level procedures for the treat- Association for the Study of Pain Diagnostic Criteria defined ment of trigeminal neuralgia, 28 in 1994, 207 Rheumatoid arthritis Systematic review of randomized controlled trials of nonpharma- Memory for pain: The relationship of pain catastrophizing to the cological interventions for fibromyalgia, 324 recall of daily rheumatoid arthritis pain, 56 Telephone survey Prevalence of common chronic pain in Hong Kong adults, 275 Secondary nonresponsiveness Temporomandibular disorders Considering the immune response to botulinum toxin, $133 Repeated assessment of temporomandibular joint pain: Reasoned Sensitivity decision-making with use of unidimensional and multidimen- A comparison of modality-specific somatosensory changes during sional pain scales, 107 menstruation in dysmenorrheic and nondysmenorrheic women Treatment of temporomandibular disorders with botulinum toxin, Sensory examination $198 Painful polyneuropathy in patients with and without diabetes: Temporomandibular joint Clinical, neurophysiologic, and quantitative sensory character- Treatment of temporomandibular disorders with botulinum toxin, istics, 122 $198 Single pain rating Testosterone Comparison of multiple against single pain intensity measurements Sex hormone suppression by intrathecal opioids: A prospective in complex regional pain syndrome type I: Analysis of 54 study, 144 patients, 234 Thermosensory Sleep Disruption of thermal perception in a multiple sclerosis patient Major depression and insomnia in chronic pain, 77 with central pain, 191 Socioeconomic status Tic douloureux Educational achievement and chronic pain disability: Mediating Pathophysiology of trigeminal neuralgia: The ignition hypothesis, 4 role of pain-related cognitions, 286 Treatment Soft-tissue syndromes A novel treatment of postherpetic neuralgia using peppermint oil, Botulinum toxin in pain management of soft tissue syndromes, 200 $147 Peripheral and Gasserian ganglion-level procedures for the treat- Somatosensory threshold ment of trigeminal neuralgia, 28 A comparison of modality-specific somatosensory changes during Treatments for chronic pain associated with spinal cord injuries: menstruation in dysmenorrheic and nondysmenorrheic women Many are tried, few are helpful, 154 Spasticity Trigeminal nerve Treatment of spasticity with botulinum toxin, $182 Stereotactic radiosurgery for the treatment of trigeminal neuralgia, Spa therapy 42 Contribution of individual spa therapies in the treatment of Trigeminal neuralgia chronic pain, 302 Diagnosis and differential diagnosis of trigeminal neuralgia, 14 Spinal cord injury Long-term pain control in trigeminal neuralgia with local anesthet- A focused review on the use of botulinum toxin for neuropathic ics using an indwelling catheter in the mandibular nerve, 196 pain, S177 Microvascular decompression, 35 Long-term use of gabapentin for treatment of pain after traumatic Pathophysiology of trigeminal neuralgia: The ignition hypothesis, 4 spinal cord injury, 116 Peripheral and Gasserian ganglion-level procedures for the treat- Treatments for chronic pain associated with spinal cord injuries: ment of trigeminal neuralgia, 28 Many are tried, few are helpful, 154 Pharmacotherapy of trigeminal neuralgia, 22 Spinal cord stimulation Stereotactic radiosurgery for the treatment of trigeminal neuralgia, Clinical effectiveness and cost-effectiveness of treatments for pa- 42 tients with chronic pain, 355 Spinal tumors Urine toxicology testing Management of progressive pain in a patient with intramedullary Role of urine toxicology testing in the management of chronic chordoma of the spine, 128 opioid therapy, S76 Spinothalamic tract Visual analog scale Disruption of thermal perception in a multiple sclerosis patient Observational visual analog scale in pediatric pain assessment: with central pain, 191 Useful tool or good riddance?, 310 Strabismus Repeated assessment of temporomandibular joint pain: Reasoned Review of the FDA-approved uses of botulinum toxins, including decision-making with use of unidimensional and multidimen- data suggesting efficacy in pain reduction, $142 sional pain scales, 107 Substance abuse Abuse and addiction issues in medically ill patients with pain: Weight lifting Attempts at clarification of terms and empirical study, $52 Lack of both sex differences and influence of resting blood pres- Abuse liability in opioid therapy for pain treatment in patients sure on muscle pain intensity, 386 with an addiction history, S61 Whiplash Assessment for addiction in pain-treatment settings, $28 Prediction of outcome in whiplash-associated disorders using West Assessment of efficacy of long-term opioid therapy in pain pa- Haven-Yale Multidimensional Pain Inventory, 238 tients with substance abuse potential, $39 Use of botulinum toxin in chronic whiplash-associated, $163 The opioid contract, S70 Whiplash-associated disorders Surgery Use of botulinum toxin in chronic whiplash-associated Microvascular decompression, 35 disorders, $163 The Clinical Journal of Pain, Vol. 18, No. 6, 2002